Section Arrow
Quote
ZTS.NYSE
- ZOETIS
Quotes are at least 15-min delayed:2026/11/14 14:46 EST
Regular Hours
Last
 83.82
+0.86 (+1.04%)
Day High 
83.85 
Prev. Close
82.96 
1-M High
89.29 
Volume 
3.15M 
Bid
83.02
Ask
84
Day Low
82.265 
Open
83.5 
1-M Low
74.25 
Market Cap 
33.71B 
Currency 美元 
P/E 13.93 
%Yield 2.53 
10-SMA 82.69 
20-SMA 81.22 
50-SMA 76.14 
52-W High 132.49 
52-W Low 68.77 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
5.93/5.97
Enterprise Value
42.95B
Balance Sheet
Book Value Per Share
8.13
Cash Flow
Cash Flow Yield
0.08
Income Statement
Total Revenue
9.47B
Operating Revenue Per Share
20.60
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AKANAkanda Corp.1.36+0.6883+102.47%-- 
HLNHaleon plc9.17+0.08+0.88%18.97PE
HIMSHims & Hers Health19.73------ 
TEVATeva Pharmaceutical Industries Limited44.5+0.85+1.95%102.3PE
VTRSViatris20.82+0.15+0.73%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companionanimal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.